Discovery and Development of Medicines
Get an overview of drug discovery, drug development, and the fundamentals of the major implicated disciplines.
People involved in the development of medicines have diverse educational backgrounds. Often their basic academic educations have not touched upon all phases of the drug discovery and development. This course aims to convey knowledge of drug discovery and development in general to the participants so they may communicate across the different fields of the process.
You will be faced with real examples from the industry and discuss problems and opportunities throughout the entire drug discovery and development process. Participants will be able to convey an understanding of the dynamics of the drug development process, communicate and cooperate across research fields as well as identifying critical factors and bottlenecks that influence the discovery and development of medicines.
We have assembled a unique team of industrial speakers, who are experts in the broad spectrum of activities involved in discovery and development of medicines. The course will cover both the theoretic background and give an industrial perspective on modern drug discovery and development.
On completion of the course, participants will have a comprehensive overview and understanding of drug discovery and development and a sound grasp of the fundamentals of the major implicated disciplines in order to:
- Upon completion of this course you will understand the drug discovery and development process.
- You will have learned how to identify correct professional terms and communicate professionally with the various specialist groups in the drug development industry.
- You will be able to identify the important transition points and milestones for the progress that require involvement of authorities.
- You will be able to plan a development process within the regulatory framework.
Professionals in need of interdisciplinary overview
The course is for professionals in the pharmaceutical industry who has a desire to get a comprehensive overview on how drugs are discovered and developed in the pharmaceutical industry today.
- Hold a relevant bachelor degree or equivalent
- Have a minimum 2 years of relevant job experience in drug development
- Be proficient in English
Find detailed information about the admission criteria.
Professor Fredrik Björkling, University of Copenhagen
Visiting experts from the pharmaceutical industry
Anders Krabbe, Novo Nordisk
Anders Lohse, Niels Clauson-Kaas
Anette Graven Sams, H. Lundbeck
Anette Hjelmsmark, Novo Nordisk
Anette Seo Torstenson, H. Lundbeck
Asser Sloth-Andersen, Novo Nordisk
Birgitte Rossau, Regeneron
Birthe Rottwitt, Novo Nordisk
Bo Maach-Møller, Eli Lilly
Dorte Bjørn-Larsen, Novo Nordisk
Dorte Kold Jensen, LEO Pharma
Erik Skibssted, Novo Nordisk
Erling Jørgensen, H. Lundbeck
Eva Møller de Bang, Novo Nordisk
Frank Larsen, H. Lundbeck
Gitte Dyhr, H. Lundbeck
Heidi Lopez de Diego, H. Lundbeck
Helle Northeved, H. Lundbeck
Jacob Nielsen, H. Lundbeck
Jan Kehler, H. Lundbeck
Jesper Frank Bastlund, H. Lundbeck
Jesper Lau, Novo Nordisk
Kevin Dolowy Dalgaard, Novo Nordisk
Kim Dekermendjian, CiToxLab
Klaus Gjervig Jensen, H. Lundbeck
Lars Hovgaard, Novo Nordisk
Louise Bastholm Jensen, LEO Pharma
Martin Neergaard, Novo Nordisk
Niels Plath, H. Lundbeck
Per Rexen, Novo Nordisk
Peter Bergqvist, Öresund Medical Writing
Søren Berg Padkjær, Novo Nordisk
Søren Møller Nielsen, H. Lundbeck
Trine Helboe, Eli Lilly
Troels V. Christensen, H. Lundbeck
Tue Hansen, Novo Nordisk
This list of lecturers may be subject to change.
This course has enhanced my understanding of research scientists and the CMC department thereby giving me tools to improve my collaboration with them.
Through the course I have achieved a greater understanding of the development processes that forms the product. This gives me an understanding of what I am a part of. The course should be mandatory for starters in the drug development industry.
This course is offered as a compulsory course in Master of Industrial Drug Development and in Master of Medicines Regulatory Affairs.
Priority is given to students enrolled on Master of Industrial Drug Development and Master of Medicines Regulatory Affairs. Once the enrolled students have been admitted to the course, the remaining seats are distributed on a first-come, first-served basis.
|Duration:||10 days on campus|
|Dates:||11-15 + 26-29 January + 1 February 2021|
|Frequency||Once every year|
|Place:||University of Copenhagen, Copenhagen, Denmark
|Course fee:||EU/EEA citizens: 21,500 DKK
Non-EU/EEA citizens: 24,975 DKK
|Level and credit:||Master course; 5 ECTS|
|Examination date:||1 February 2020 from 15:00-17:00|
|Application deadline:||15 November 2020
To be admitted, you must meet the admission criteria for Master of Industrial Drug Development